110 related articles for article (PubMed ID: 20080906)
1. Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P; Perez-DE-Lis M; Diaz-Lagares C; Bove A; Soto MJ; Jimenez I; Belenguer R; Siso A; Muxí A; Pons F
J Rheumatol; 2010 Mar; 37(3):585-90. PubMed ID: 20080906
[TBL] [Abstract][Full Text] [Related]
2. Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors.
Brito-Zerón P; Ramos-Casals M; Bove A; Sentis J; Font J
Rheumatology (Oxford); 2007 Aug; 46(8):1359-62. PubMed ID: 17569749
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis for modified Schall's classification by stimulation test with dynamic scintigraphy in Sjögren's syndrome.
Zhu GW; Gao Z; Feng HB; Qiu JJ
Int J Rheum Dis; 2020 Mar; 23(3):381-391. PubMed ID: 31863640
[TBL] [Abstract][Full Text] [Related]
4. Sjogren's syndrome in Israel: primary versus secondary disease.
Tishler M; Aharon A; Ehrenfeld M; Avni I; Bendet E; Bombardieri S; Yaron M; Shoenfeld Y
Clin Rheumatol; 1994 Sep; 13(3):438-41. PubMed ID: 7835006
[TBL] [Abstract][Full Text] [Related]
5. Parotid sialography and minor salivary gland biopsy in the diagnosis of Sjögren's syndrome. A comparative study of 84 patients.
Vitali C; Tavoni A; Simi U; Marchetti G; Vigorito P; d'Ascanio A; Neri R; Cristofani R; Bombardieri S
J Rheumatol; 1988 Feb; 15(2):262-7. PubMed ID: 3258917
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients.
Pérez-De-Lis M; Akasbi M; Sisó A; Diez-Cascon P; Brito-Zerón P; Diaz-Lagares C; Ortiz J; Perez-Alvarez R; Ramos-Casals M; Coca A
Lupus; 2010 Jul; 19(8):941-8. PubMed ID: 20581017
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance and diagnostic usefulness of anti-centromere antibody in Sjögren's syndrome.
Kitagawa T; Shibasaki K; Toya S
Clin Rheumatol; 2012 Jan; 31(1):105-12. PubMed ID: 21670951
[TBL] [Abstract][Full Text] [Related]
8. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of salivary gland ultrasonographic scoring system in primary Sjogren's syndrome: a comparison with scintigraphy and biopsy.
Milic VD; Petrovic RR; Boricic IV; Marinkovic-Eric J; Radunovic GL; Jeremic PD; Pejnovic NN; Damjanov NS
J Rheumatol; 2009 Jul; 36(7):1495-500. PubMed ID: 19487274
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of labial salivary biopsy in Sjogren's syndrome: report of 182 cases].
Andretta M; Ianniello A; Ostuni PA; Siniscalchi E; Cusatelli P; Todesco S
Acta Otorhinolaryngol Ital; 1995 Feb; 15(1):40-6. PubMed ID: 7597901
[TBL] [Abstract][Full Text] [Related]
11. Utility and safety of parotid gland biopsy in Sjögren's syndrome.
Biasi D; Mocella S; Caramaschi P; Carletto A; Baracchino F; Colletti V; Bambara LM
Acta Otolaryngol; 1996 Nov; 116(6):896-9. PubMed ID: 8973729
[TBL] [Abstract][Full Text] [Related]
12. Predicting Sjögren's syndrome in patients with recent-onset SLE.
Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
[TBL] [Abstract][Full Text] [Related]
13. Sjögren's syndrome: comparison of assessments with quantitative salivary gland scintigraphy and contrast sialography.
Aung W; Yamada I; Umehara I; Ohbayashi N; Yoshino N; Shibuya H
J Nucl Med; 2000 Feb; 41(2):257-62. PubMed ID: 10688108
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for the clinical severity of keratoconjunctivitis sicca in patients with Sjogren's syndrome.
Chung JK; Kim MK; Wee WR
Br J Ophthalmol; 2012 Feb; 96(2):240-5. PubMed ID: 21558290
[TBL] [Abstract][Full Text] [Related]
15. Serological profiles in subgroups of patients with Sjögren's syndrome.
Manoussakis MN; Tzioufas AG; Pange PJ; Moutsopoulos HM
Scand J Rheumatol Suppl; 1986; 61():89-92. PubMed ID: 3473654
[TBL] [Abstract][Full Text] [Related]
16. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and visual evaluation of salivary and thyroid glands in patients with primary Sjögren's syndrome using salivary gland scintigraphy: relationship with clinicopathological features of salivary, lacrimal and thyroid glands.
Güne S; Yilmaz S; Karalezli A; Aktaş A
Nucl Med Commun; 2010 Jul; 31(7):666-72. PubMed ID: 20545046
[TBL] [Abstract][Full Text] [Related]
18. [Long-term follow-up of 43 patients with Sjögren's syndrome].
Cui G; Sugai S; Ogawa Y; Takeshita S; Masaki Y; Fukutoku M
Ryumachi; 1997 Dec; 37(6):770-80. PubMed ID: 9492564
[TBL] [Abstract][Full Text] [Related]
19. Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome.
Vissink A; Kalk WW; Mansour K; Spijkervet FK; Bootsma H; Roodenburg JL; Kallenberg CG; Nieuw Amerongen AV
Arch Otolaryngol Head Neck Surg; 2003 Sep; 129(9):966-71. PubMed ID: 12975269
[TBL] [Abstract][Full Text] [Related]
20. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).
Ramos-Casals M; Brito-Zerón P; Solans R; Camps MT; Casanovas A; Sopeña B; Díaz-López B; Rascón FJ; Qanneta R; Fraile G; Pérez-Alvarez R; Callejas JL; Ripoll M; Pinilla B; Akasbi M; Fonseca E; Canora J; Nadal ME; de la Red G; Fernández-Regal I; Jiménez-Heredia I; Bosch JA; Ayala MD; Morera-Morales L; Maure B; Mera A; Ramentol M; Retamozo S; Kostov B; ;
Rheumatology (Oxford); 2014 Feb; 53(2):321-31. PubMed ID: 24162151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
